Showing results (651-660 of 889) with videos related to

Sort By:
Pageof 89
Drugs in R&D|November 3, 2023
Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor AgonistHandan He, Jinzi J Wu
Drugs in R&D|October 13, 2023
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference ProductGreg Cantin, Qian Liu, Bhavana Shah, et al.
Drugs in R&D|July 19, 2023
Biochemical Characterization of a New 10% IVIG Preparation [IgG Next Generation (BT595)/Yimmugo®] Obtained from a Manufacturing Process Preserving IgA/IgM Potential of Human PlasmaChristian Duellberg, Achim Hannappel, Steffen Kistner, et al.
Drugs in R&D|August 28, 2023
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple SclerosisMartin Vališ, Anat Achiron, Hans Peter Hartung, et al.
Drugs in R&D|February 26, 2026
Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody: Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety ProfileHuilun Chu, Guili Xu, Yunlong Liu, et al.
Drugs in R&D|April 3, 2026
Arylpiperazine Derivative NAF19 Inhibits Prostate Cancer Activity and Its Molecular MechanismsHua Jiang, Mingzhen Xu, Songsong Jiang, et al.
Drugs in R&D|December 21, 2016
Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in JapanSachie Kubota, Kazuyuki Saito, Shunsuke Ono, et al.
Drugs in R&D|September 9, 2026
Comparative Pharmacokinetics of Trientine Dihydrochloride Capsules: A Randomized, Open-Label, Reference-Controlled, Two-Period Crossover Study in Healthy VolunteersChristian J Hartmann, Frank Tacke, Isabelle Mohr, et al.
Drugs in R&D|November 26, 2014
Very short-term effects of the dipeptidyl peptidase-4 inhibitor sitagliptin on the secretion of insulin, glucagon, and incretin hormones in Japanese patients with type 2 diabetes mellitus: analysis of meal tolerance test dataKazuki Murai, Tomoyuki Katsuno, Jun-ichiro Miyagawa, et al.
Drugs in R&D|June 24, 2016
Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus PatientsAki Okamoto, Hirohide Yokokawa, Hironobu Sanada, et al.
Pageof 89